Evolus, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $297.2M | $266.3M | $202.1M | $148.6M | $99.7M |
| Cost of revenue | $100.1M | $84.0M | $64.5M | $58.8M | $43.5M |
| Gross profit | $197.1M | $182.3M | $137.6M | $89.8M | — |
| Selling, general & administrative | $220.8M | $198.0M | $164.9M | $141.8M | $112.1M |
| Research and development | $9.6M | $9.2M | $6.6M | $4.7M | $2.1M |
| Operating income | -$32.7M | -$34.4M | -$49.2M | -$65.3M | -$44.4M |
| Interest expense | $19.7M | $18.7M | $13.8M | $9.1M | $1.4M |
| Pretax income | -$51.0M | -$49.8M | -$61.5M | -$74.3M | -$46.8M |
| Income tax expense | $677,000 | $664,000 | $176,000 | $95,000 | $42,000 |
| Net income | -$51.6M | -$50.4M | -$61.7M | -$74.4M | -$46.8M |
| Balance Sheet | |||||
| Cash and equivalents | $53.8M | $87.0M | $62.8M | $53.9M | $146.3M |
| Current assets | $142.9M | $151.3M | $112.4M | $100.8M | $178.8M |
| Total assets | $225.9M | $232.6M | $189.0M | $178.0M | $257.5M |
| Current liabilities | $75.3M | $63.0M | $48.3M | $46.5M | $57.7M |
| Total liabilities | $249.0M | $227.0M | $209.7M | $159.5M | $175.6M |
| Total debt | $150.0M | $125.0M | $125.0M | $75.0M | $75.0M |
| Stockholders' equity | -$23.1M | $5.5M | -$20.7M | $18.5M | $81.9M |
| Cash Flow Statement | |||||
| Cash from operations | -$42.3M | -$18.0M | -$34.0M | -$84.9M | -$33.4M |
| Depreciation and amortization | $7.5M | $5.3M | $5.1M | $3.7M | $5.6M |
| Stock-based compensation | $20.7M | $22.3M | $16.5M | $10.8M | $9.6M |
| Capital expenditure | $3.4M | $1.5M | $473,000 | $1.6M | $393,000 |
| Free cash flow | -$45.7M | -$19.5M | -$34.5M | -$86.5M | -$33.8M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 65.9M · Free float 77.2%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.